000 01320 a2200361 4500
005 20250513212607.0
264 0 _c20000713
008 200007s 0 0 eng d
022 _a1084-9785
024 7 _a10.1089/cbr.1999.14.153
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarbet, J
245 0 0 _aPretargeting with the affinity enhancement system for radioimmunotherapy.
_h[electronic resource]
260 _bCancer biotherapy & radiopharmaceuticals
_cJun 1999
300 _a153-66 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Bispecific
_xpharmacokinetics
650 0 4 _aCarcinoma, Medullary
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdiagnostic imaging
650 0 4 _aNeoplasms
_xdiagnostic imaging
650 0 4 _aRadioimmunodetection
650 0 4 _aRadioimmunotherapy
_xmethods
650 0 4 _aThyroid Neoplasms
_xdiagnostic imaging
700 1 _aKraeber-Bodéré, F
700 1 _aVuillez, J P
700 1 _aGautherot, E
700 1 _aRouvier, E
700 1 _aChatal, J F
773 0 _tCancer biotherapy & radiopharmaceuticals
_gvol. 14
_gno. 3
_gp. 153-66
856 4 0 _uhttps://doi.org/10.1089/cbr.1999.14.153
_zAvailable from publisher's website
999 _c10801400
_d10801400